Polyneuron is an early stage Swiss pharmaceutical company that is committed to the development of new drugs for the treatment of autoimmune disorders.
Location: Switzerland, Basel-City
Member count: 11-50
Total raised: $70.205442M
Founded date: 2014
Investors 4
| Date | Name | Website |
| - | Sofinnova ... | sofinnovap... |
| - | Venture Ki... | venturekic... |
| - | VentureLab | venturelab... |
| - | HBM Partne... | hbmpartner... |
Funding Rounds 5
| Date | Series | Amount | Investors | Deal News |
| 28.04.2021 | Grant | $1.320104M | - | - |
| 22.09.2020 | Series A | $40.085002... | - | venturelab... |
| 29.03.2019 | Series A | $22.613065... | New Enterp... | startuptic... |
| 14.05.2018 | Seed | $3.098373M | - | finsmes.co... |
| 12.05.2016 | Seed | $3.088898M | - | startuptic... |
Mentions in press and media 44
| Date | Title | Description | Category | Author | Source |
| 20.10.2020 | New manage... | Aktiia SA is a Swiss-US star... | Expansion | - | startuptic... |
| 20.10.2020 | New manage... | Aktiia SA is a Swiss-US start-... | - | - | startuptic... |
| 22.09.2020 | Polyneuron... | Polyneuron Pharmaceuticals AG,... | Switzerlan... | - | finsmes.co... |
| 16.09.2020 | Polyneuron... | Polyneuron extends Series A to... | - | - | venturelab... |
| 16.09.2020 | Polyneuron... | Polyneuron will use the proc... | Financing | - | startuptic... |
| 16.09.2020 | Polyneuron... | Polyneuron will use the procee... | Investment... | - | startuptic... |
| 16.09.2020 | Polyneuron... | Polyneuron was a Venture Kick ... | - | - | venturekic... |
| 12.06.2020 | FDA approv... | GTX medical developed Go-2 s... | Success | - | startuptic... |
| 12.06.2020 | FDA approv... | GTX medical developed Go-2 sys... | Developmen... | - | startuptic... |
| 07.04.2020 | Polyneuron... | Basel-based Polyneuron Pharm... | Expansion ... | - | startuptic... |
Show more